Introduction: Unknown Primary Cancer

Seminars in Oncology

Volumn 36, Issue 1, 2009, Pages 6-7

  Greco, F Anthony ^a   Hainsworth, John D ^a  

^a SARAH CANNON RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CANCER THERAPY; DISEASE FREE SURVIVAL; EDITORIAL; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS;

HUMANS; NEOPLASMS, UNKNOWN PRIMARY;

EID: 58549119806     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.10.007     Document Type: Editorial

References (3)

1. Pentheroudakis G., Golfinopoulos V., and Pavlidis N. Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer 43 (2007) 2026-2036
2. Greco F.A., and Hainsworth J.D. Cancer of unknown primary site. In: DeVita Jr. V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles and practice oncology. 8th ed. (2008), Lippincott, Philadelphia 2363-2387
3. Varadhachary G., Talantov D., Raber M., Meng C., Hess K.R., Jatkoe T., et al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26 (2008) 4442-4448